Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treosulfan pharmacokinetics in children undergoing allogeneic stem cell transplantation
NL-OMON41480Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2013
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of treosulfan in hematopoietic malignancies, Immunogenetic disorder and hemoglobinopathies, sponsored by Leiden University Medical Center. Primary endpoints: Treosulfan clearance, Treosulfan half-life and 3 more. Started Apr 2013; status: active, not recruiting.
02
Drugs
treosulfan
03
Conditions
hematopoietic malignanciesImmunogenetic disorderhemoglobinopathies
Beyond the preview
Go deeper on NL-OMON41480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41480.